A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Roche: Data for Breast Cancer Drug Candidate Giredestrant Support Potential Differentiated Status - Morningstar Canada
Roche: Data for Breast Cancer Drug Candidate Giredestrant Support Potential Differentiated Status Morningstar Canada
OLMA Stock Doubles After Roche Cancer Drug Trial Yields Positive Results - Stocktwits
OLMA Stock Doubles After Roche Cancer Drug Trial Yields Positive Results Stocktwits
New experimental drug could transform care for cancer patients - The Independent
New experimental drug could transform care for cancer patients The Independent
Is Now the Moment to Reassess Roche After Its Drug Pipeline Developments and 17% Stock Jump? - simplywall.st
Is Now the Moment to Reassess Roche After Its Drug Pipeline Developments and 17% Stock Jump? simplywall.st
Roche oral drug shown to keep breast cancer at bay, boosting shares - Reuters
Roche oral drug shown to keep breast cancer at bay, boosting shares Reuters
Roche Just Unleashed a Drug That Could Disrupt the Entire MS Market - Yahoo Finance
Roche Just Unleashed a Drug That Could Disrupt the Entire MS Market Khac Phu Nguyen November 10, 2025 1 min read ROG.SW +1.38% This article first appeared on GuruFocus....
Roche's experimental MS drug hits main goal in one of two key trials - Reuters
Roche's experimental MS drug hits main goal in one of two key trials Reuters
Roche taps an AI specialist to craft new brain drugs - BioPharma Dive
Roche taps an AI specialist to craft new brain drugs BioPharma Dive
Roche in ongoing discussions with US government over drug pricing, CEO says - Pharmaceutical Technology
Roche in ongoing discussions with US government over drug pricing, CEO says Pharmaceutical Technology
Roche shares fall as new drug sales disappoint - Reuters
Roche shares fall as new drug sales disappoint Reuters
Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial - CNBC
Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial CNBC
Roche, muscling into weight-loss drug race, advances obesity treatment to late-stage trial - Reuters
Roche, muscling into weight-loss drug race, advances obesity treatment to late-stage trial Reuters
Roche to acquire liver drug developer 89bio for up to $3.5 billion - Reuters
Roche to acquire liver drug developer 89bio for up to $3.5 billion Reuters
Roche begins building $700M obesity drug manufacturing facility in N.C. - Fierce Pharma
Roche begins building $700M obesity drug manufacturing facility in N.C. Fierce Pharma
Roche considering selling drugs directly to US patients, CEO says - Reuters
Roche considering selling drugs directly to US patients, CEO says Reuters
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page